Press Releases | Medtronic

Month Year

Email alerts

Oct 27, 2011

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

MINNEAPOLIS, Oct 27, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against...
Oct 26, 2011

Medtronic Starts Landmark Study of Hypertension Treatment

U.S. Clinical Trial of Symplicity(R) Renal Denervation System(TM) Enrolls First Patient

MINNEAPOLIS, Oct 26, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT) announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity(R) Renal Denervation...
Oct 17, 2011

Medtronic Announces 510(k) Clearance for theAquamantys(R)3 System with Combined Hemostatic Sealing and Cutting Functionality

MINNEAPOLIS, Oct 17, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for its Aquamantys(R)3...
Oct 17, 2011

Medtronic Elects Michael O. Leavitt to the Board of Directors

MINNEAPOLIS, Oct 17, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that its Board of Directors unanimously voted to elect Michael O. Leavitt, founder and chairman of Leavitt...
Oct 13, 2011

Medtronic Introduces Two Next-Generation Cardiovascular Devices in Japan

Integrity(R) Coronary Stent Redefines Deliverability with Continuous Sinusoid Technology; Endurant(R) AAA Stent Graft Expands Applicability of Endovascular Aortic Repair

MINNEAPOLIS, Oct 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced plans to introduce two of its next-generation cardiovascular devices in Japan, the world's second largest...
Oct 10, 2011

Medtronic Announces Results from TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation

First Ever Randomized, Controlled Clinical Trial in Persistent Atrial Fibrillation (AF) Patients

VENICE, Italy & MINNEAPOLIS, Oct 10, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced results from its Tailored Treatment of Permanent Atrial Fibrillation (TTOP-AF) clinical...
Sep 27, 2011

Medtronic Announces Start of Pivotal Trial for EngagerTM Transcatheter Aortic Valve Implantation System

Study will evaluate new therapy option for patients suffering from valvular heart disease

MINNEAPOLIS, Sep 27, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the start of the Engager(TM) European Pivotal Trial to pursue CE (Conformité Européenne) Mark for the...
Sep 20, 2011

Medtronic Responds to United Nations High-Level Meeting on Noncommunicable Diseases

MINNEAPOLIS, Sep 20, 2011 (BUSINESS WIRE) -- Following are statements from Herb Riband, Medtronic vice president of external affairs, and Dr. Jacob Gayle, vice president of Medtronic Foundation...
Sep 20, 2011

Jury Awards Medtronic $101 Million in Patent Suit against NuVasive

MEMPHIS, Tenn., Sep 20, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced today that a jury in the United States District Court of the Southern District of California in San Diego,...
Sep 15, 2011

Medtronic Announces 510(k) Clearance for the TSRH(R) Spinal System Pedicle Screw for the Treatment of Adolescent Idiopathic Scoliosis

AIS is the Most Common Type of Scoliosis Seen in Adolescents and Affects Nearly One Million Adolescents in the U.S. Alone

MEMPHIS, Tenn., Sep 15, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it received a second clearance from the Food and Drug Administration (FDA) to treat adolescent idiopathic...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa